html5-img
1 / 11

Aarkstore - Type 1 Diabetes (Juvenile Diabetes)

This report provides comprehensive information on the therapeutic development for Type 1 Diabetes (Juvenile Diabetes), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. Browse full report @ http://goo.gl/RdYj4j

kaveriRai9023
Télécharger la présentation

Aarkstore - Type 1 Diabetes (Juvenile Diabetes)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pharmaceuticals & Healthcare Market Research Reports Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2014 For More Information Visit : www.aarkstore.com

  2. Summary Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2014, provides an overview of the Type 1 Diabetes (Juvenile Diabetes)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Type 1 Diabetes (Juvenile Diabetes), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Type 1 Diabetes (Juvenile Diabetes) and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. For More Information Visit : www.aarkstore.com

  3. Scope - The report provides a snapshot of the global therapeutic landscape of Type 1 Diabetes (Juvenile Diabetes)- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Type 1 Diabetes (Juvenile Diabetes) and enlists all their major and minor projects- The report summarizes all the dormant and discontinued pipeline projects - A review of the Type 1 Diabetes (Juvenile Diabetes) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages- A detailed assessment of monotherapy and combination therapy pipeline projects- Coverage of the Type 1 Diabetes (Juvenile Diabetes) pipeline on the basis of target, MoA, route of administration and molecule type- Latest news and deals relating related to pipeline products For More Information Visit : www.aarkstore.com

  4. Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage- Develop strategic initiatives by understanding the focus areas of leading companies- Identify and understand important and diverse types of therapeutics under development for Type 1 Diabetes (Juvenile Diabetes)- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline- Devise corrective measures for pipeline projects by understanding Type 1 Diabetes (Juvenile Diabetes) pipeline depth and focus of Indication therapeutics- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline For More Information Visit : www.aarkstore.com

  5. Table of Content Introduction 7Type 1 Diabetes (Juvenile Diabetes) Overview 8Therapeutics Development 9Type 1 Diabetes (Juvenile Diabetes) - Therapeutics under Development by Companies 11Type 1 Diabetes (Juvenile Diabetes) - Therapeutics under Investigation by Universities/Institutes 20Type 1 Diabetes (Juvenile Diabetes) - Pipeline Products Glance 22Type 1 Diabetes (Juvenile Diabetes) - Products under Development by Companies 26Type 1 Diabetes (Juvenile Diabetes) - Products under Investigation by Universities/Institutes 38Type 1 Diabetes (Juvenile Diabetes) - Companies Involved in Therapeutics Development 40Type 1 Diabetes (Juvenile Diabetes) - Therapeutics Assessment 135Drug Profiles 147Type 1 Diabetes (Juvenile Diabetes) - Recent Pipeline Updates 400Type 1 Diabetes (Juvenile Diabetes) - Dormant Projects 476Type 1 Diabetes (Juvenile Diabetes) - Discontinued Products 479Type 1 Diabetes (Juvenile Diabetes) - Product Development Milestones 480Appendix 489 For More Information Visit : www.aarkstore.com

  6. List of Tables Number of Products under Development for Type 1 Diabetes (Juvenile Diabetes), H2 2014 30Number of Products under Development for Type 1 Diabetes (Juvenile Diabetes) - Comparative Analysis, H2 2014 31Number of Products under Development by Companies, H2 2014 33Number of Products under Development by Companies, H2 2014 (Contd..1) 34Number of Products under Development by Companies, H2 2014 (Contd..2) 35Number of Products under Development by Companies, H2 2014 (Contd..3) 36Number of Products under Development by Companies, H2 2014 (Contd..4) 37Number of Products under Development by Companies, H2 2014 (Contd..5) 38Number of Products under Development by Companies, H2 2014 (Contd..6) 39Number of Products under Development by Companies, H2 2014 (Contd..7) 40Number of Products under Investigation by Universities/Institutes, H2 2014 42Comparative Analysis by Late Stage Development, H2 2014 43Comparative Analysis by Clinical Stage Development, H2 2014 44Comparative Analysis by Early Stage Development, H2 2014 45 For More Information Visit : www.aarkstore.com

  7. List of Figures Number of Products under Development for Type 1 Diabetes (Juvenile Diabetes), H2 2014 30Number of Products under Development for Type 1 Diabetes (Juvenile Diabetes) - Comparative Analysis, H2 2014 31Number of Products under Development by Companies, H2 2014 32Number of Products under Investigation by Universities/Institutes, H2 2014 41Comparative Analysis by Late Stage Development, H2 2014 43Comparative Analysis by Clinical Stage Development, H2 2014 44Comparative Analysis by Early Stage Products, H2 2014 45Assessment by Monotherapy Products, H2 2014 156Assessment by Combination Products, H2 2014 157Number of Products by Top 10 Targets, H2 2014 158Number of Products by Stage and Top 10 Targets, H2 2014 158Number of Products by Top 10 Mechanism of Actions, H2 2014 161Number of Products by Stage and Top 10 Mechanism of Actions, H2 2014 161Number of Products by Top 10 Routes of Administration, H2 2014 164Number of Products by Stage and Top 10 Routes of Administration, H2 2014 164 For More Information Visit : www.aarkstore.com

  8. Browse Full Report Or Sample Request @ http://www.aarkstore.com/pharmaceuticals-healthcare/60608/type-1-diabetes-juvenile-diabetes-pipeline-review-h2-2014 For More Information Visit : www.aarkstore.com

  9. Related Reports • Fabry Disease-Pipeline Insights, 2015 • Ocular Hypertension-Pipeline Insights, 2015 • Fallopian Tube Cancer-Pipeline Insights, 2015 • Ocular Inflammation-Pipeline Insights, 2015 • Familial AdenomatousPolyposis Coli-Pipeline Insights, 2015 • Ocular Pain-Pipeline Insights, 2015 • Familial AmyloidPolyneuropathy (TransthyretinAmyloidosis, Corino de Andrades Disease)-Pipeline Insights, 2015 • Oligodendroglioma-Pipeline Insights, 2015 For More Information Visit : www.aarkstore.com

  10. Follow Us https://www.facebook.com/aarkstoredotcom https://twitter.com/aarkstore https://plus.google.com/+Aarkstoredotcom/posts https://www.linkedin.com/company/aarkstore-enterprise For More Information Visit : www.aarkstore.com

  11. Contact Us Office Address Office No. - 809, 8th Floor,B-Wing, Mahaavir Icon, Plot No.- 89 & 90, Sector-15,CBD-Belapur, Navi Mumbai – 400614, Maharashtra, India. Mail us at contact@aarkstore.com 24/7 Online Support: +91 9987295242 General Inquiries : +91 - 22 2756 4953 For More Information Visit : www.aarkstore.com

More Related